drugset / Trial / NCT01665599
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 3 clinical trial in adult hypogonadal males with baseline serum testosterone concentrations \<300 ng/dL. The purpose of this study is to evaluate the safety and efficacy of testosterone gel (2%) delivered using an applicator.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-04
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone | Small molecule | 46 mg | Topical |